Accurate mass measurements by Fourier transform mass spectrometry in the study of advanced glycation end products/peptides
- 14 January 2003
- journal article
- research article
- Published by Wiley in Journal of Mass Spectrometry
- Vol. 38 (2) , 196-205
- https://doi.org/10.1002/jms.431
Abstract
The Maillard reaction occurring between sugars and amino groups is important in living systems. When amino groups belonging to protein chains are involved, the Maillard reaction has been invoked as responsible for protein cross-linking and the production of ‘toxic’ compounds. The reaction leads to the production of a heterogeneous group of substances, usually called advanced glycation end products (AGEs). Classical analytical approaches, such as spectroscopic (ultraviolet, fluorescence) and mass spectrometric (matrix-assisted laser desorption/ionization, liquid chromatography/electrospray ionization mass spectrometry) methods, have shown that the digestion mixture is highly complex. However, there are clear differences between the digestion mixtures of glycated and unglycated human serum albumin (HSA). In the former case, possible glycated peptides belonging to the AGE peptide class may be identified. Tandem mass spectrometric experiments on selected species seemed to be promising as regards structural information, but it was thought of interest to undertake the present investigation, based on liquid chromatography/electrospray ionization Fourier transform mass spectrometry, in order to obtain definitive results on their elemental composition. Using this approach, about 20 glycated peptides were detected and their possible structures were postulated by examining the known sequence of HSA. Copyright © 2003 John Wiley & Sons, Ltd.Keywords
This publication has 24 references indexed in Scilit:
- Circulating advanced glycation peptides in streptozotocin-induced diabetic rats: Evidence for preferential modification of IgG light chainsLife Sciences, 1998
- Advanced Glycation End Products and Their Recognition by Macrophage and Macrophage-Derived CellsDiabetes, 1996
- Renal fate of circulating advanced glycated end products (AGE): evidence for reabsorption and catabolism of AGE-peptides by renal proximal tubular cellsDiabetologia, 1996
- Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency.Proceedings of the National Academy of Sciences, 1994
- Immunological quantification of advanced glycosylation end-products in the serum of patients on hemodialysis or CAPDKidney International, 1994
- Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failureThe Lancet, 1994
- Advanced Glycosylation End Products in Continuous Ambulatory Peritoneal Dialysis PatientsAmerican Journal of Kidney Diseases, 1993
- Human and rat mesangial cell receptors for glucose-modified proteins: potential role in kidney tissue remodelling and diabetic nephropathy.The Journal of Experimental Medicine, 1991
- Advanced Glycosylation End Products in Patients with Diabetic NephropathyNew England Journal of Medicine, 1991
- Lysosomal Enzymes as Agents of Turnover of Soluble Cytoplasmic ProteinsEuropean Journal of Biochemistry, 1975